Mechanisms of chemopreventive effects of 8-methoxypsoralen against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung adenomas

Carcinogenesis

Volumn 26, Issue 11, 2005, Pages 1947-1955

  Miyazaki, Masafumi ^a   Yamazaki, Hiroshi ^a   Takeuchi, Hijiri ^b   Saoo, Kousuke ^b   Yokohira, Masanao ^b   Masumura, Ken Ichi ^c   Nohmi, Takehiko ^c   Funae, Yoshihiko ^d   Imaida, Katsumi ^b   Kamataki, Tetsuya ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^d OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; ALANINE AMINOTRANSFERASE; COUMARIN; CYTOCHROME P450 2A; CYTOCHROME P450 2A5; CYTOCHROME P450 4A; MESSENGER RNA; METHOXSALEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CATALYSIS; CHEMOPROPHYLAXIS; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; FEMALE; GENE MUTATION; GENETIC ENGINEERING; IN VITRO STUDY; IN VIVO STUDY; LUNG ADENOMA; LUNG CARCINOGENESIS; MICROSOME; MOUSE; MOUSE STRAIN; MUTAGENIC ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALMONELLA TYPHIMURIUM;

ADENOMA; ANIMALS; ANTINEOPLASTIC AGENTS; ARYL HYDROCARBON HYDROXYLASES; CARCINOGENS; CHEMOPREVENTION; COUMARINS; CYTOCHROME P-450 ENZYME SYSTEM; ESCHERICHIA COLI PROTEINS; FEMALE; HUMANS; LUNG NEOPLASMS; METHOXSALEN; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSOMES; MIXED FUNCTION OXYGENASES; MUTATION; NITROSAMINES; PENTOSYLTRANSFERASES; PROTEINS; SALMONELLA TYPHIMURIUM; STEROID HYDROXYLASES;

EID: 27744555294     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi156     Document Type: Article

References (58)

1. Hecht,S.S. (1998) Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem. Res. Toxicol., 11, 559-603.
2. Hoffmann,D. and Hoffmann,I. (1997) The changing cigarette, 1950-1995. J. Toxicol. Environ. Health, 50, 307-364.
3. Hecht,S.S. (1999) Tobacco smoke carcinogens and lung cancer. J. Natl Cancer Inst., 91, 1194-1210.
4. Hecht,S.S. (2002) Cigarette smoking and lung cancer: Chemical mechanisms and approaches to prevention. Lancet Oncol., 3, 461-469.
5. Crespi,C.L., Penman,B.W., Gelboin,H.V. and Gonzalez,F.J. (1991) A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6. Carcinogenesis, 12, 1197-1201.
6. 6-methylguanine is a critical determinant of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenesis in A/J mouse lung. Cancer Res., 51, 5557-5564.
7. Ronai,Z.A., Gradia,S., Peterson,L.A. and Hecht,S.S. (1993) G to A transitions and G to T transversions in codon 12 of the Ki-ras oncogene isolated from mouse lung tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and related DNA methylating and pyridyloxobutylating agents. Carcinogenesis, 14, 2419-2422.
8. Porter,T.D. and Coon,M.J. (1991) Cytochrome P-450. Multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms. J. Biol. Chem., 266, 13469-13472.
9. Nelson,D.R., Kamataki,T., Waxman,D.J., Guengerich,F.P., Estabrook,R.W., Feyereisen,R., Gonzalez,F.J., Coon,M.J., Gunsalus,I.C., Gotoh,O., Okuda,K. and Nebert,D.W. (1993) The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell. Biol., 12, 1-51.
10. Nelson,D.R., Koymans,L., Kamataki,T., Stegeman,J.J., Feyereisen,R., Waxman,D.J., Waterman,M.R., Gotoh,O., Coon,M.J., Estabrook,R.W., Gunsalus,I.C. and Nebert,D.W. (1996) P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 6, 1-42.
11. Guengerich,F.P. and Shimada,T. (1991) Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol., 4, 391-407.
12. Guengerich,F.P. (2001) Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem. Res. Toxicol., 14, 611-650.
13. Yamano,S., Nagata,K., Yamazoe,Y., Kato,R., Gelboin,H.V. and Gonzalez,F.J. (1989) cDNA and deduced amino acid sequences of human P450 IIA3 (CYP2A3). Nucleic Acids Res., 17, 4888.
14. Mace,K., Bowman,E.D., Vautravers,P., Shields,P.G., Harris,C.C. and Pfeifer,A.M. (1998) Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues. Eur. J. Cancer, 34, 914-920.
15. Crawford,E.L., Weaver,D.A., DeMuth,J.P., Jackson,C.M., Khuder,S.A., Frampton,M.W., Utell,M.J., Thilly,W.G. and Willey,J.C. (1998) Measurement of cytochrome P450 2A6 and 2E1 gene expression in primary human bronchial epithelial cells. Carcinogenesis, 19, 1867-1871.
16. Yamazaki,H., Inui,Y., Yun,C.H., Guengerich,F.P. and Shimada,T. (1992) Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis, 13, 1789-1794.
17. Kushida,H., Fujita,K., Suzuki,A., Yamada,M., Endo,T., Nohmi,T. and Kamataki,T. (2000) Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase. Carcinogenesis, 21, 1227-1232.
18. Fernandez-Salguero,P., Hoffman,S., Cholerton,S., Mohrenweiser,H., Raunio,H., Rautio,A., Pelkonen,O., Huang,J., Evans,W., Idle,J. and Gonzalez,F.J. (1995) A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 allele. Am. J. Hum. Genet., 57, 651-660.
19. Ujjin,P., Satarug,S., Vanavanitkun,Y., Daigo,S., Ariyoshi,N., Yamazaki,H., Reilly,P.E., Moore,M.R. and Kamataki,T. (2002) Variation in coumarin 7-hydroxylase activity associated with genetic polymorphism of cytochrome P450 2A6 and the body status of iron stores in adult Thai males and females. Pharmacogenetics, 12, 241-249.
20. Nunoya,K., Yokoi,T., Kimura,K., Inoue,K., Kodama,T., Funayama,M., Nagashima,K., Funae,Y., Green,C., Kinoshita,M. and Kamataki,T. (1998) A new deleted allele in the human cytochrome P450 2A6 (CYP2A6) gene found in individuals showing poor metabolic capacity to coumarin and (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride (SM-12502). Pharmacogenetics, 8, 239-249.
21. Nunoya,K.I., Yokoi,T., Kimura,K., Kainuma,T., Satoh,K., Kinoshita,M. and Kamataki,T. (1999) A new CYP2A6 gene deletion responsible for the in vivo polymorphic metabolism of (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride in humans. J. Pharmacol. Exp. Ther., 289, 437-442.
22. Ariyoshi,N., Sawamura,Y. and Kamataki,T. (2001) A novel single nucleotide polymorphism altering stability and activity of CYP2A6. Biochem. Biophys. Res. Commun., 281, 810-814.
23. Daigo,S., Takahashi,Y., Fujieda,M., Ariyoshi,N., Yamazaki,H., Koizumi,W., Tanabe,S., Nagayama,S., Ikeda,K., Nishioka,Y. and Kamataki,T. (2002) A novel mutant allele of the CYP2A6 gene (CYP2A6*11) found in a cancer patient who showed poor metabolic phenotype towards tegafur. Pharmacogenetics, 12, 299-306.
24. Miyamoto,M., Umetsu,Y., Dosaka-Akita,H., Sawamura,Y., Yokota,J., Kunitoh,H., Nemoto,N., Sato,K., Ariyoshi,N. and Kamataki,T. (1999) CYP2A6 gene deletion reduces susceptibility to lung cancer. Biochem. Biophys. Res. Commun., 261, 658-660.
25. Ariyoshi,N., Miyamoto,M., Umetsu,Y., Kunitoh,H., Dosaka-Akita,H., Sawamura,Y., Yokota,J., Nemoto,N., Sato,K. and Kamataki,T. (2002) Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers. Cancer Epidemiol. Biomarkers Prev., 11, 890-894.
26. Fujieda,M., Yamazaki,H., Saito,T., Kiyotani,K., Gyramfi,M., Sakurai,M., Dosaka-Akita,H., Sawamura,Y., Yokota,J., Kunitoh,H. and Kamataki,T. (2004) Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers. Carcinogenesis, 25, 2451-2458.
27. Scott,B.R., Pathak,M.A. and Mohn,G.R. (1976) Molecular and genetic basis of furocoumarin reactions. Mutat. Res., 39, 29-74.
28. Melski,J.W., Tanenbaum,L., Parrish,J.A., Fitzpatrick,T.B. and Bleich,H.L. (1977) Oral methoxsalen photochemotherapy for the treatment of psoriasis: A cooperative clinical trial. J. Invest. Dermatol., 68, 329-335.
29. Parrish,J.A., Fitzpatrick,T.B., Tanenbaum,L. and Pathak,M.A. (1974) Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N. Engl. J. Med., 291, 1207-1211.
30. Koenigs,L.L., Peter,R.M., Thompson,S.J., Rettie,A.E. and Trager,W.F. (1997) Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen. Drug Metab. Dispos., 25, 1407-1415.
31. Maenpaa,J., Sigusch,H., Raunio,H., Syngelma,T., Vuorela,P., Vuorela,H. and Pelkonen,O. (1993) Differential inhibition of coumarin 7-hydroxylase activity in mouse and human liver microsomes. Biochem. Pharmacol., 45, 1035-1042.
32. Yamazaki,H., Mimura,M., Sugahara,C. and Shimada,T. (1994) Catalytic roles of rat and human cytochrome P450 2A enzymes in testosterone 7α -and coumarin 7-hydroxylations. Biochem. Pharmacol., 48, 1524-1527.
33. Takeuchi,H., Saoo,K., Yokohira,M., Ikeda,M., Maeta,H., Miyazaki,M., Yamazaki,H., Kamataki,J. and Imaida,K. (2003) Pretreatment with 8-methoxypsoralen, a potent human CYP2A6 inhibitor, strongly inhibits lung tumorigenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in female A/J mice. Cancer Res., 63, 7581-7583.
34. Fujita Ki,K., Nakayama,K., Yamazaki,Y., Tsuruma,K., Yamada,M., Nohmi,T. and Kamataki,T. (2001) Construction of Salmonella typhimurium YG7108 strains, each coexpressing a form of human cytochrome P450 with NADPH-cytochrome P450 reductase. Environ. Mol. Mutagen., 38, 329-338.
35. Omura,T. and Sato,R. (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem., 239, 2379-2385.
36. Phillips,A.H. and Langdon,R.G. (1962) Hepatic triphosphopyridine nucleotide (TPN)-cytochrome c reductase: Isolation, characterization and kinetic studies. J. Biol. Chem., 237, 2652-2660.
37. Maron,D.M. and Ames,B.N. (1983) Revised methods for the Salmonella mutagenicity test. Mutat. Res., 113, 173-215.
38. Guengerich,F. (1994) Analysis and characterization of enzyme. In: Hayes,A.W. (ed.), Principles and Methods of Toxicology. Raven Press, NY, pp. 1259-1313.
39. Nohmi,T., Katoh,M., Suzuki,H., Matsui,M., Yamada,M., Watanabe,M., Suzuki,M., Horiya,N., Ueda,O., Shibuya,T., Ikeda,H. and Sofuni,T. (1996) A new transgenic mouse mutagenesis test system using Spi- and 6-thioguanine selections. Environ. Mol. Mutagen., 28, 465-470.
40. Rehm,S., Word,J. and Sass,B. (1994) Tumors of the lungs. In: Turusov,V.S. and Mohrs,U. (eds), Pathology of Tumors in Laboratory Animals, Vol. 2, Tumours of the Mouse. Lyon, pp. 325-355.
41. Smith,T.J., Guo,Z.Y., Thomas,P.E., Chung,F.L., Morse,M.A., Elkind,K. and Yang,C.S. (1990) Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes and its inhibition by isothiocyanates. Cancer Res., 50, 6817-6822.
42. Guo,Z., Smith,T.J., Thomas,P.E. and Yang,C.S. (1991) Metabolic activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone as measured by DNA alkylation in vitro and its inhibition by isothiocyanates. Cancer Res., 51, 4798-4803.
43. Smith,T.J., Guo,Z., Gonzalez,F.J., Guengerich,F.P., Stoner,G.D. and Yang,C.S. (1992) Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells. Cancer Res., 52, 1757-1763.
44. Smith,T.J., Guo,Z., Hong,J.Y., Ning,S.M., Thomas,P.E. and Yang,C.S. (1992) Kinetics and enzyme involvement in the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in microsomes of rat lung and nasal mucosa. Carcinogenesis, 13, 1409-1414.
45. Burkhart,B.A., Harada,N. and Negishi,M. (1985) Sexual dimorphism of testosterone 15 alpha-hydroxylase mRNA levels in mouse liver. cDNA cloning and regulation. J. Biol. Chem., 260, 15357-15361.
46. Kaipainen,P., Nebert,D.W. and Lang,M.A. (1984) Purification and characterization of a microsoma] cytochrome P-450 with high activity of coumarin 7-hydroxylase from mouse liver. Eur. J. Biochem., 144, 425-431.
47. Juvonen,R.O., Shkumatov,V.M. and Lang,M.A. (1988) Purification and characterization of a liver microsomal cytochrome P-450 isoenzyme with a high affinity and metabolic capacity for coumarin from pyrazole-treated D2 mice. Eur. J. Biochem., 171, 205-211.
48. Iwasaki,M., Lindberg,R.L., Juvonen,R.O. and Negishi,M. (1993) Site-directed mutagenesis of mouse steroid 7 alpha-hydroxylase (cytochrome P-450(7) alpha): Role of residue-209 in determining steroid-cytochrome P-450 interaction. Biochem. J., 291, 569-573.
49. 15α gene. J. Biol. Chem., 264, 6465-6471.
50. Honkakoski,P. and Negishi,M. (1997) The structure, function, and regulation of cytochrome P450 2A enzymes. Drug Metab. Rev., 29, 977-996.
51. Szutowski,M., Lukasik,M., Wawer,Z., Chrobak,K., Michalska,M., Borzecka,K. and Brzezinski,J. (2002) In vivo effect of 5- and 8-methoxypsoralens and cimetidine on R,S-warfarin metabolism in rat. J. Appl. Toxicol., 22, 327-332.
52. Ono,S., Hatanaka,T., Hotta,H., Satoh,T., Gonzalez,F.J. and Tsutsui,M. (1996) Specificity of substrate and inhibitor probes for cytochrome P450s: Evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes. Xenobiotica, 26, 681-693.
53. Draper,A.J., Madan,A. and Parkinson,A. (1997) Inhibition of coumarin 7-hydroxylase activity in human liver microsomes. Arch. Biochem. Biophys., 341, 47-61.
54. Kharasch,E.D., Hankins,D.C. and Taraday,J.K. (2000) Sinple-dose methoxsalen effects on human cytochrome P-450 2A6 activity. Drug Metab. Dispos., 28, 28-33.
55. von Pressentin,M.M., Chen,M. and Guttenplan,J.B. (2001) Mutagenesis induced by
56. Castonguay,A., Tjalve,H. and Hecht,S.S. (1983) Tissue distribution of tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its metabolites in F344 rats. Cancer Res., 43, 630-638.
57. Miyazaki,M., Sugawara,E., Yoshimura,T., Yamazaki,H. and Kamataki,T. (2005) Mutagenic activation of betel quid-specific N-nitrosamines catalyzed by human cytochrome P450 coexpressed with NADPH-cytochrome P450 reductase in Salmonella typhimurium YG7108. Mutat. Res., 581, 165-171.
58. Topcu,Z., Chiba,I., Fujieda,M., Shibata,T., Ariyoshi,N., Yamazaki,H., Sevgican,F., Muthumala,M., Kobayashi,H, and Kamataki,T. (2002) CYP2A6 gene deletion reduces oral cancer risk in betel quid chewers in Sri Lanka. Carcinogenesis, 23, 595-598.